Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-084619
Filing Date
2026-07-17
Accepted
2026-07-17 16:05:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2620412-1_424b5.htm 424B5 498888
2 GRAPHIC lg_tvardi-4c.jpg GRAPHIC 15572
3 GRAPHIC tb_pipeline2-4c.jpg GRAPHIC 119789
4 GRAPHIC tb_pipeline-4c.jpg GRAPHIC 52854
  Complete submission text file 0001104659-26-084619.txt   742720
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-295496 | Film No.: 261183762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)